CD8A and cervical intraepithelial neoplasia: Given that DNAvaccines can already induce CD8+ T‐cell responses in patients to cause histopathological regression of HPV‐driven cervical dysplasia,4 the finding is relevant and whether DLnanovaccines can further improve the clinical response rates should be explored.